• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国结直肠癌同期腹膜转移癌的诊治现状分析:国内16家医疗中心1003例报告

[The status analysis of diagnosis and treatment of synchronous peritoneal carcinomatosis from colorectal cancer in China: a report of 1 003 cases in 16 domestic medical centers].

作者信息

Wang H M, Wang G Y, Huang Y, Ren L, Zhang H, Wu A W, Han J G, Shu X G, Wang G Y, Yang Y C, Wang Z Q, Cui M, Lu Y, Feng B, Zhou J P, Wu B, Tong W D, Wang H, Luo Y X, Wu X J, Cai J, Yao H W, Wang L

机构信息

Department of Colorectal Surgery, the Sixth Affiliated Hospital of Sun Yat-Sen University, Guangzhou 510655, China.

Department of Colorectal Surgery, the Second Affiliated Hospital of Harbin Medical University, Harbin 150086, China.

出版信息

Zhonghua Wai Ke Za Zhi. 2019 Sep 1;57(9):666-672. doi: 10.3760/cma.j.issn.0529-5815.2019.09.005.

DOI:10.3760/cma.j.issn.0529-5815.2019.09.005
PMID:31474058
Abstract

To analyze the status of domestic surgical treatment of synchronous peritoneal carcinomatosis from colorectal cancer in China. Clinicopathological data of patients who underwent surgery from October 2003 to October 2018 in 16 domestic medical centers was retrospectively analyzed. Excel database was created which covered 77 fields of 7 parts: baseline information of patients, laboratory tests, imaging tests, chemoradiotherapy information, intra-operative findings, postoperative pathology and follow-up data. The Wilcoxon rank-sum test was used for comparison of the measurement data between groups. The χ(2) test was used for comparison of the categorical data between groups. The survival curve was calculated by the Kaplan-Meier method. Of the 1 003 patients, there were 575 male and 428 female patients with the age of (58.5±14.1) years (range: 18 to 92 years). In a total of 920 patients, the carcinoma of sigmoid colon was performed in 292 cases (31.8%) with the highest ratio. The proportion of patients with liver metastasis and lung metastasis were 27.9% (219/784) and 8.3% (64/769). Preoperative detection of carcino-embryonic antigen level was the most common method in China (87.74%, 880/1 003), and the positive rate was 64.5% (568/880). The correct rate of preoperative imaging tests was 40.7% (280/688). The ratio of peritoneal carcinomatosis index (PCI) scores between 0 and 10 was the highest (59.6%, 170/285). Two hundred and sixty-two (27.0%) patients were performed by totally laparoscopic operation in 971 patients. The resection of primary tumor was performed in 588 of the 817 patients (72.0%). In a total of 457 cases, 253 (55.4%) patients were performed cytoreduction which group scored completeness of cytoreduction (CCR) 0. The postoperative hyperthermic intraperitoneal chemotherapy was implemented in 70 of the 334 cases (21.0%). Among 1 003 cases, 562 cases (56.03%) had complete follow-up data and the median overall survival was 15 months. The primary tumor resection and the CCR scores were affected by the PCI scores. The patients underwent primary tumor resection (187/205 . 26/80, χ(2)=105.085, 0.000) and the patients were performed cytoreduction which scored CCR 0 or CCR 1 (162/204 . 8/78, -10.465, 0.000) had significant difference between the groups of PCI<20 and ≥20. There was a close correlation between the surgical method and the CCR scores (-3.246,0.001).When the maximum degree of tumor reduction was planned, most surgeons would choose laparotomy. The overall survival time was longer in patients with primary tumor resection (0.000). The median survival time was 18.6 months in the group of primary tumor resection. It is difficult to diagnose the synchronous peritoneal carcinomatosis from colorectal cancer before the operation. Primary tumor resection has an obvious effect to prolong the survival time. It is necessary to standardize the treatment of peritoneal metastasis.

摘要

分析我国结直肠癌同时性腹膜转移癌的外科治疗现状。回顾性分析2003年10月至2018年10月期间国内16家医疗中心行手术治疗患者的临床病理资料。创建了Excel数据库,涵盖患者基本信息、实验室检查、影像学检查、放化疗信息、术中所见、术后病理及随访数据7个部分的77个字段。采用Wilcoxon秩和检验比较组间计量资料,采用χ²检验比较组间分类资料。采用Kaplan-Meier法计算生存曲线。1003例患者中,男性575例,女性428例,年龄(58.5±14.1)岁(范围:18~92岁)。920例患者中,乙状结肠癌292例(31.8%),比例最高。肝转移和肺转移患者比例分别为27.9%(219/784)和8.3%(64/769)。术前检测癌胚抗原水平是我国最常用的方法(87.74%,880/1003),阳性率为64.5%(568/880)。术前影像学检查的正确率为40.7%(280/688)。腹膜转移癌指数(PCI)评分在0至10之间的比例最高(59.6%,170/285)。971例患者中262例(27.0%)行全腹腔镜手术。817例患者中588例(72.0%)切除了原发肿瘤。457例患者中,253例(55.4%)行细胞减灭术,其中细胞减灭完全性(CCR)评分为0。334例患者中70例(21.0%)术后行腹腔热灌注化疗。1003例患者中,562例(56.03%)有完整随访数据,中位总生存期为15个月。原发肿瘤切除及CCR评分受PCI评分影响。PCI<20组与≥20组患者行原发肿瘤切除(187/205.26/80,χ²=105.085,P=0.000)及CCR评分为0或CCR 1的细胞减灭术(162/204.8/78,z=-10.465,P=0.000)组间差异有统计学意义。手术方式与CCR评分密切相关(r=-3.

相似文献

1
[The status analysis of diagnosis and treatment of synchronous peritoneal carcinomatosis from colorectal cancer in China: a report of 1 003 cases in 16 domestic medical centers].中国结直肠癌同期腹膜转移癌的诊治现状分析:国内16家医疗中心1003例报告
Zhonghua Wai Ke Za Zhi. 2019 Sep 1;57(9):666-672. doi: 10.3760/cma.j.issn.0529-5815.2019.09.005.
2
Clinical outcomes of complete cytoreduction with concurrent liver resection followed by hyperthermic intraperitoneal chemotherapy for synchronous peritoneal and liver metastatic colorectal cancer.同步腹膜和肝脏转移性结直肠癌患者行完全细胞减灭术联合肝脏切除术和腹腔内热灌注化疗的临床疗效。
World J Surg Oncol. 2019 Dec 11;17(1):214. doi: 10.1186/s12957-019-1746-x.
3
Treatment of peritoneal carcinomatosis from colonic cancer by cytoreduction, peritonectomy and hyperthermic intraperitoneal chemotherapy (HIPEC). Experience of ten years.结直肠癌腹膜转移的细胞减灭术、腹膜切除术和腹腔热灌注化疗(HIPEC)治疗。十年经验。
In Vivo. 2010 Jan-Feb;24(1):79-84.
4
Treatment of intraoperatively detected peritoneal carcinomatosis of colorectal origin with cytoreductive surgery and intraperitoneal chemotherapy.结直肠来源术中发现的腹膜癌病采用细胞减灭术和腹腔内化疗治疗。
World J Surg Oncol. 2018 Mar 27;16(1):70. doi: 10.1186/s12957-018-1369-7.
5
Analysis of prognostic factors in seventy patients having a complete cytoreduction plus perioperative intraperitoneal chemotherapy for carcinomatosis from colorectal cancer.对70例接受了完全肿瘤细胞减灭术加围手术期腹腔内化疗以治疗结直肠癌所致癌性腹膜炎患者的预后因素分析。
J Am Coll Surg. 2006 Dec;203(6):878-86. doi: 10.1016/j.jamcollsurg.2006.08.024. Epub 2006 Oct 25.
6
CEA to peritoneal carcinomatosis index (PCI) ratio is prognostic in patients with colorectal cancer peritoneal carcinomatosis undergoing cytoreduction surgery and intraperitoneal chemotherapy: A retrospective cohort study.癌胚抗原与腹膜癌指数(PCI)比值对接受细胞减灭术及腹腔内化疗的结直肠癌腹膜转移患者具有预后评估价值:一项回顾性队列研究
J Surg Oncol. 2018 Mar;117(4):725-736. doi: 10.1002/jso.24911. Epub 2017 Dec 19.
7
Peritoneal Carcinomatosis in Colorectal Cancers - Management Perspective Needs a Change.结直肠癌腹膜转移瘤——管理视角需要改变。
Clin Colorectal Cancer. 2017 Jun;16(2):e1-e6. doi: 10.1016/j.clcc.2016.08.001. Epub 2016 Aug 30.
8
Synchronous Liver Resection, Cytoreductive Surgery, and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Liver and Peritoneal Metastases: A Systematic Review and Meta-analysis.同步肝切除、细胞减灭术和腹腔内热灌注化疗治疗结直肠癌肝和腹膜转移:系统评价和荟萃分析。
Dis Colon Rectum. 2021 Jun 1;64(6):754-764. doi: 10.1097/DCR.0000000000002027.
9
Laparoscopic cytoreductive surgery and early postoperative intraperitoneal chemotherapy for patients with colorectal cancer peritoneal carcinomatosis: initial results from a single center.腹腔镜减瘤手术联合术后早期腹腔内化疗治疗结直肠癌腹膜转移癌患者:单中心初步结果
Surg Endosc. 2014 May;28(5):1555-62. doi: 10.1007/s00464-013-3351-3. Epub 2013 Dec 25.
10
Cytoreduction plus hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis in colorectal cancer patients: a single-center cohort study.结直肠癌患者腹膜转移肿瘤细胞减灭术联合腹腔热灌注化疗的单中心队列研究。
World J Surg Oncol. 2019 Mar 27;17(1):58. doi: 10.1186/s12957-019-1602-z.

引用本文的文献

1
Analysis of gastrointestinal function and prognostic value of tumor markers in patients with laparoscopic radical resection of colorectal cancer.腹腔镜根治性切除结直肠癌患者的胃肠功能分析及肿瘤标志物的预后价值
Am J Transl Res. 2022 Sep 15;14(9):6618-6626. eCollection 2022.
2
Development and Validation of a Prognostic Nomogram for Colorectal Cancer Patients With Synchronous Peritoneal Metastasis.同步性腹膜转移结直肠癌患者预后列线图的开发与验证
Front Oncol. 2021 Jul 1;11:615321. doi: 10.3389/fonc.2021.615321. eCollection 2021.